Unknown

Dataset Information

0

Identification of genes conferring resistance to 5-fluorouracil.


ABSTRACT: Astrocyte elevated gene-1 (AEG-1) is overexpressed in >90% of human hepatocellular carcinoma (HCC) patients and plays a significant role in mediating aggressive progression of HCC. AEG-1 is known to augment invasion, metastasis, and angiogenesis, and we now demonstrate that AEG-1 directly contributes to another important hallmark of aggressive cancers, that is, resistance to chemotherapeutic drugs, such as 5-fluorouracil (5-FU). AEG-1 augments expression of the transcription factor LSF that regulates the expression of thymidylate synthase (TS), a target of 5-FU. In addition, AEG-1 enhances the expression of dihydropyrimidine dehydrogenase (DPYD) that catalyzes the initial and rate-limiting step in the catabolism of 5-FU. siRNA-mediated inhibition of AEG-1, LSF, or DPYD significantly increased the sensitivity of HCC cells to 5-FU in vitro and a lentivirus delivering AEG-1 siRNA in combination with 5-FU markedly inhibited growth of HCC cells xenotransplanted in athymic nude mice when compared to either agent alone. The present studies highlight 2 previously unidentified genes, AEG-1 and LSF, contributing to chemoresistance. Inhibition of AEG-1 might be exploited as a therapeutic strategy along with 5-FU-based combinatorial chemotherapy for HCC, a highly fatal cancer with currently very limited therapeutic options.

SUBMITTER: Yoo BK 

PROVIDER: S-EPMC2722317 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of genes conferring resistance to 5-fluorouracil.

Yoo Byoung Kwon BK   Gredler Rachel R   Vozhilla Nicollaq N   Su Zao-zhong ZZ   Chen Dong D   Forcier Talitha T   Shah Khalid K   Saxena Utsav U   Hansen Ulla U   Fisher Paul B PB   Sarkar Devanand D  

Proceedings of the National Academy of Sciences of the United States of America 20090721 31


Astrocyte elevated gene-1 (AEG-1) is overexpressed in >90% of human hepatocellular carcinoma (HCC) patients and plays a significant role in mediating aggressive progression of HCC. AEG-1 is known to augment invasion, metastasis, and angiogenesis, and we now demonstrate that AEG-1 directly contributes to another important hallmark of aggressive cancers, that is, resistance to chemotherapeutic drugs, such as 5-fluorouracil (5-FU). AEG-1 augments expression of the transcription factor LSF that regu  ...[more]

Similar Datasets

| S-EPMC3561415 | biostudies-literature
| S-EPMC7074223 | biostudies-literature
| S-EPMC4414854 | biostudies-literature
| S-EPMC7823563 | biostudies-literature
| S-SCDT-EMM-2020-13466 | biostudies-other
| S-EPMC10849323 | biostudies-literature
| S-EPMC4617896 | biostudies-literature
| S-EPMC4220099 | biostudies-literature
| S-EPMC5544663 | biostudies-literature
| S-EPMC2964223 | biostudies-literature